These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16000195)

  • 1. The biological impact of estrogens on gender differences in congestive heart failure.
    Schönfelder G
    Cardiovasc Res; 2005 Sep; 67(4):573-4. PubMed ID: 16000195
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of biological sex and diet on the development of heart failure.
    Konhilas JP; Leinwand LA
    Circulation; 2007 Dec; 116(23):2747-59. PubMed ID: 18056540
    [No Abstract]   [Full Text] [Related]  

  • 3. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple faces of the actions of estrogen].
    Tapanainen J
    Duodecim; 2003; 119(22):2179-81. PubMed ID: 14702806
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogenic hormone action in the heart: regulatory network and function.
    Babiker FA; De Windt LJ; van Eickels M; Grohe C; Meyer R; Doevendans PA
    Cardiovasc Res; 2002 Feb; 53(3):709-19. PubMed ID: 11861041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormones and vascular function: introduction.
    Man RY; Leung SW
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):799-800. PubMed ID: 17600561
    [No Abstract]   [Full Text] [Related]  

  • 7. Iptakalim: a new or just another KCO?
    Costa AD
    Cardiovasc Res; 2009 Aug; 83(3):417-8. PubMed ID: 19515796
    [No Abstract]   [Full Text] [Related]  

  • 8. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthesis-patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression.
    Ruel M; Al-Faleh H; Kulik A; Chan KL; Mesana TG; Burwash IG
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1036-44. PubMed ID: 16678587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of hormone replacement therapy on the cardiovascular system].
    Shviro I; Leitersdorf E
    Harefuah; 1995 May; 128(9):561-6. PubMed ID: 7797159
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effects of estrogens in the brain and cardiovascular system.
    Brann DW; Mahesh VB
    Mol Cell Endocrinol; 2014 May; 389(1-2):1. PubMed ID: 24560889
    [No Abstract]   [Full Text] [Related]  

  • 14. Harnessing hormonal signaling for cardioprotection.
    Ballard VL; Edelberg JM
    Sci Aging Knowledge Environ; 2005 Dec; 2005(51):re6. PubMed ID: 16371658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricle volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure.
    Horii T; Suma H; Isomura T; Nomura F; Hoshino J
    Ann Thorac Surg; 2006 Oct; 82(4):1349-54; discussion 1354-5. PubMed ID: 16996932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroso-redox interactions in the cardiovascular system.
    Zimmet JM; Hare JM
    Circulation; 2006 Oct; 114(14):1531-44. PubMed ID: 17015805
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogen and its receptors in cancer.
    Chen GG; Zeng Q; Tse GM
    Med Res Rev; 2008 Nov; 28(6):954-74. PubMed ID: 18642351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms underlying the cardiovascular actions of oestrogens.
    Ling S; Komesaroff P; Sudhir K
    Clin Sci (Lond); 2006 Aug; 111(2):107-18. PubMed ID: 16831130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen actions in the cardiovascular system.
    Mendelsohn ME
    Climacteric; 2009; 12 Suppl 1():18-21. PubMed ID: 19811235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.